Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CENTRAL WASHINGTON SLEEP DIAGNOSTIC CENTER, PLLC

NPI: 1639441165 · BREWSTER, WA 98812 · Occupational Medicine Clinic/Center · NPI assigned 01/30/2012

$1.23M
Total Medicaid Paid
25,594
Total Claims
22,671
Beneficiaries
28
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHAEGER, ERIC (OWNER)
NPI Enumeration Date01/30/2012

Related Entities

Other providers sharing the same authorized official: HAEGER, ERIC

ProviderCityStateTotal Paid
CENTRAL WASHINGTON SLEEP DIAGNOSTIC CENTER, PLLC MOSES LAKE WA $6.90M
CENTRAL WASHINGTON SLEEP DIAGNOSTIC CENTER, PLLC WENATCHEE WA $2.30M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,304 $111K
2019 1,946 $144K
2020 4,945 $206K
2021 4,499 $198K
2022 4,368 $241K
2023 4,641 $197K
2024 2,891 $136K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6,798 5,132 $490K
E0601 Continuous positive airway pressure (cpap) device 990 987 $205K
A7034 Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap 671 668 $69K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,144 671 $68K
A7038 Filter, disposable, used with positive airway pressure device 6,721 6,698 $66K
A4604 Tubing with integrated heating element for use with positive airway pressure device 1,094 1,090 $65K
A7035 Headgear used with positive airway pressure device 1,354 1,349 $49K
A7030 Full face mask used with positive airway pressure device, each 268 267 $42K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 220 196 $30K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 260 254 $23K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 380 310 $21K
A7046 Water chamber for humidifier, used with positive airway pressure device, replacement, each 1,313 1,306 $17K
A7039 Filter, non disposable, used with positive airway pressure device 1,085 1,079 $15K
A7031 Face mask interface, replacement for full face mask, each 278 278 $14K
Q3014 Telehealth originating site facility fee 769 564 $13K
E0562 Humidifier, heated, used with positive airway pressure device 40 40 $11K
E0470 Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device) 13 13 $8K
A7032 Cushion for use on nasal mask interface, replacement only, each 194 194 $7K
A7033 Pillow for use on nasal cannula type interface, replacement only, pair 112 112 $5K
A7036 Chinstrap used with positive airway pressure device 304 303 $5K
80305 310 151 $3K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 17 12 $2K
84703 268 122 $2K
95806 35 34 $2K
A7037 Tubing used with positive airway pressure device 26 26 $960.88
99457 877 787 $754.20
99308 Subsequent nursing facility care, per day, straightforward 21 14 $405.47
99309 Subsequent nursing facility care, per day, low to moderate complexity 32 14 $322.80